Pipeline栓塞装置治疗颅内假性动脉瘤
多机构回顾性研究纳入2014至2017年间7家机构收治的19例颅内假性动脉瘤患者,均以Pipeline栓塞装置治疗。18例有随访影像的患者中14例(78%)完全闭塞、2例近完全闭塞(11%),2例(11%)短期随访出现显著进展并需牺牲颈内动脉,无患者出现新发神经功能缺损或出血。作者认为在筛选合适的患者中,血流导向支架可作为牺牲载瘤动脉的可行替代方案,并推荐影像学短期和长期随访。
要点
- 19例颅内假性动脉瘤患者接受Pipeline栓塞装置治疗,平均直径8.8 mm,18例(95%)累及颈内动脉。
- 18例有随访影像者中14例(78%)完全闭塞、2例(11%)近完全闭塞,2例(11%)短期随访显著进展需牺牲颈内动脉。
- 无患者出现装置置入继发的新发神经功能缺损或恶化,无假性动脉瘤出血或再出血。
核心结论
- 在筛选合适的患者中,血流导向支架可能是牺牲载瘤动脉的可行替代方案。
- 鉴于假性动脉瘤相关高致残率与死亡率,作者推荐对血流导向支架治疗患者进行影像学短期和长期随访。
研究设计与样本
- 多机构回顾性研究,纳入2014至2017年间7家机构收治的颅内假性动脉瘤并以Pipeline栓塞装置治疗的患者19例。
- 回顾并发症及临床与影像学结局。
主要发现
- 医源性损伤与外伤构成该系列的大多数病因。
- 平均假性动脉瘤直径8.8 mm,19例中18例(95%)累及颈内动脉。
- 7例(37%)以套叠方式置入多枚Pipeline栓塞装置。
- 18例有随访影像的患者中,14例(78%)完全闭塞,2例(11%)近完全闭塞。
- 2例(11%)短期随访发现假性动脉瘤显著进展并需牺牲颈内动脉。
临床怎么用
- 作者认为,在筛选合适的患者中,血流导向支架可能是牺牲载瘤动脉的可行替代方案。
- 作者推荐对接受血流导向支架治疗的患者进行影像学短期和长期随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Intracranial pseudoaneurysms (PSAs) are associated with high rupture and mortality rates and have traditionally been treated by parent vessel sacrifice. There has been recent interest in using flow-diverting devices for treatment of these complex lesions while preserving flow through the parent artery. The objective of this study is to examine the safety and efficacy of these devices in the treatment of intracranial PSA. METHODS: We performed a multi-institutional retrospective study of intracranial PSAs treated with the Pipeline Embolization Device (PED) between 2014 and 2017 at 7 institutions. Complications and clinical and radiographic outcomes were reviewed. RESULTS: A total of 19 patients underwent PED placement for intracranial PSA. Iatrogenic injury and trauma comprised most etiologies in our series. The mean pseudoaneurysm diameter was 8.8 mm, and 18 of 19 PSAs (95%) involved the internal carotid artery (ICA). Multiple PEDs were deployed in a telescoping fashion in 7 patients (37%). Of the 18 patients with follow up imaging, 14 (78%) achieved complete pseudoaneurysm obliteration and 2 achieved near-complete obliteration (11%). Two patients (11%) were found to have significant pseudoaneurysm progression on short-term follow-up and required ICA sacrifice. No patients experienced new neurologic deficits or deterioration secondary to PED placement. No patients experienced bleeding or rebleeding from PSA. CONCLUSIONS: In well-selected patients, the use of flow-diverting stents may be a feasible alternative to parent vessel sacrifice. Given the high morbidity and mortality associated with PSA, we recommend short- and long-term radiographic follow-up for patients treated with flow-diverting stents.
引用
- Chen SH, McCarthy DJ, Sheinberg D, et al. Pipeline Embolization Device for the Treatment of Intracranial Pseudoaneurysms. World Neurosurg. 2019. PMID: 30849553. doi:10.1016/j.wneu.2019.02.135
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。